Literature DB >> 32153153

Analysis of two single-nucleotide polymorphisms (rs2241766 and rs1501299) of the adiponectin gene in patients with coronary artery disease and coronary slow flow.

Muhammad Diah1,2, Aznan Lelo3, Zulfikri Muhktar4, Dharma Lindarto5.   

Abstract

Aim To investigate the association of two single-nucleotide polymorphisms (SNPs) of the adiponectin gene (+45 T>G [rs2241766] and +276 G>T [rs1501299]) in patients with coronary artery disease (CAD), coronary slow flow (CSF) and in healthy subjects. Methods The study investigated 90 patients: 30 patients with coronary artery disease (the CAD group), 30 with only coronary slow flow (the CSF group) and 30 healthy patients. Genotyping was carried out for two of these SNPs in the adiponectin gene using the TaqMan polymerase chain reaction (PCR) method. Results There were no significant differences in the frequencies of polymorphism +45T>G (rs2241766) genotype (p=0.464) and the allele (p=0.362). There were also no significant differences between the +276 G>T (rs1501299) genotype and the allele (p=0.624 and p=0.281, respectively). Conclusion Our study indicated that in patients with CAD, CSF, and in healthy subjects, the SNP +276G>T and +45T>G alleles of the adiponectin gene were not associated. Copyright© by the Medical Assotiation of Zenica-Doboj Canton.

Entities:  

Keywords:  cardiovascular disease; coronary angiography; genetic association

Mesh:

Substances:

Year:  2020        PMID: 32153153     DOI: 10.17392/1102-20

Source DB:  PubMed          Journal:  Med Glas (Zenica)        ISSN: 1840-0132


  1 in total

1.  Endothelial nitric oxide synthase Asp298Glu (894G/T) gene polymorphism as a possible risk factor for the coronary slow flow phenomenon among Iranians.

Authors:  Yeganeh Karimi; Fatemeh Sehati; Ali Sarreshtedari; Mina Mirzad; Yasaman Khalili; Reza Kiani; Elham Taheri Bajgan; Maryam Hosseini Moghadam; Farzaneh Mehrvarz; Hooman Bakhshandeh; Maryam Parham; Mahshid Malakootian; Parham Sadeghipour
Journal:  BMC Cardiovasc Disord       Date:  2022-06-30       Impact factor: 2.174

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.